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Introduction 
Esophageal and tracheal stenting is an effective palliative 
treatment of malignant tracheo-esophageal (TEF) and 
trachea-mediastinal fistula (TMF) to relieve dyspnea and 
dysphagia (1), and to improve quality of life (2). Rigid 
bronchoscopy (RB) is commonly used to place tracheal 
stents to seal the lesion from the airway side (3). However, 
general anesthesia and jet ventilation required for RB may 
cause gastric distension, pneumomediastinum or worsening 
of the fistula (4). Thus, a safe sedation technique enabling 
RB in spontaneous respiration might be promising.
Dexmedetomidine is an α2 receptor agonist with 
sympatholytic and sedative characteristics, which has been 
shown to enable moderate sedation for several procedures 
including airway foreign body removal through RB in 
pediatric patients (5). Apart from one publication (6), to 
our knowledge there are no reports on tracheal stenting 
through RB using dexmedetomidine. 
Here, we present three cases with successful tracheal 
stent placement through RB in moderate sedation and 
spontaneous respiration using dexmedetomidine to 
seal TEF or TMF. All patients gave the consent to this 
technique and a general consent to present the data. 
Case presentation
Case 1
A 57-year-old male with squamous cell carcinoma 
(cT4cN2cM0, UICC IIIB) in the posterior mediastinum 
presented with an esophageal stent penetrating into the 
trachea, subsequently causing a 95% stenosis in the lower 
trachea (Figure 1A). Successful placement of a 18-14-
14 mm fully covered aerstent® Y Carina-Stent (Leufen, 
Medical GmbH, bess AG, Berlin, Germany) through a 
12mm Storz rigid tracheoscope (Karl Storz SE & Co. KG, 
Tuttlingen, Germany) was performed to seal the leakage 
using fluoroscopy (Figure 1B). Anesthesia was provided 
using a continuous infusion pump with remifentantil (TCI 
0.5–1 mcg/mL) and dexmedetomidine. For the latter, a 
dosage of 4 µg/kg/h over 15 minutes or until Richmond 
Agitation Sedation Scale (RASS) reached −1 or −2, followed 
by reduction to 0.7 to 1 µg/kg/h until approximately 
10 minutes before end of procedure. In addition, a few 
propofol boli were added (Table 1). The patient tolerated 
the procedure without negative recalls, was arousable and 
breathing spontaneously throughout the entire intervention. 
The postinterventional follow-up was uneventful, and 
the patient was able to maintain a satisfactory life without 
dyspnea for 12 months thereafter.
Case 2
A 68-year-old male patient with relapsing small cell 
lung carcinoma (cT3cN2M0) presented with a 30 mm 
TMF in the anterior trachea and aspiration pneumonia. 
TMF was sealed using oxidized regenerated cellulose 
(Tabotamp®, Ethicon Inc., Somerville, NJ, USA) and 
fibrin sealant (Tisseel®, Baxter AG, Opfikon, Switzerland) 
(Figure 2A,B). Thereafter, an 18-14-14 mm fully covered 
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aerstent® Y Carina-Stent was placed through a 12 mm rigid 
tracheoscope using fluoroscopy (Figure 2C). Anesthesia was 
provided using the identical drug and dose regimen as in 
case 1 (Table 1). The patient remained awake, yet stable and 
free of dyspnea and pain throughout the whole intervention. 
The post-interventional follow-up was uneventful. The 
patient’s main symptoms, dyspnea and dysphagia, were 
relieved. However, the patient died two weeks later of 
disease progression.
Case 3
A 72-year-old male with relapsing squamous cell carcinoma 
of the proximal esophagus (cT3cN1M0) presented with 
an esophageal stent perforating the trachea about 3 cm 
below the vocal cords and causing 60% tracheal stenosis 
and complete obstruction of the left main bronchus 
(Figure 3A). Placement of a 16-12-12 mm aerstent® 
Y Carina Stent with the proximal end right below the 
cranial fistula orifice (Figure 3B) and stent extension 
using a partially covered, straight 16×40 mm UltraflexTM 
Stent (Figure 3C) (BostonScientific, Marlborough, MA, 
USA) using a 14 mm rigid tracheoscope and fluoroscopy 
succeeded by administering several propofol boli, 
remifentanil and continuous infusion of dexmedetomidine 
(Table 1). A small gap between stent and trachea wall 
remained at the end (Figure 3D), and the esophagus stent 
was left unchanged. Anesthesia was again provided using 
a similar drug and dose regimen as in case 1. However, 
the tapering dose of dexmedetomidine ranged between 
1–2.1 µg/kg/h until approximately 10 minutes before end of 
procedure. The interventions were tolerated without further 
distress or complications and relieved the patient effectively 
of his symptoms, most of all dyspnea and dysphagia. Seven 
days later he died of disease progression.
Discussion
The general condition of patients with TEF/TMF is 
generally poor due to recurrent aspiration pneumonia and 
the underlying cancer itself. Additionally, life expectancy 
precludes major surgery. Endoscopic stenting is the 
treatment of choice in the majority of cases (1). Eventually 
immediate closure of the lesion is of highest priority to 
prevent repeated aspiration. It is recommended to close 
the esophageal fistula orifice using coated self-expanding 
metallic stents as initial step (1). For isolated esophageal 
stenting procedures, analgosedation using combined 
administration of propofol and opiates seems adequate. 
Figure 1 Rigid bronchoscopy of case 1. (A) Upper tracheal view with penetrated esophagus stent causing a 95% stenosis; (B) lower tracheal 
view after stenting using an aerstent® Y Carina-Stent (Leufen, Medical GmbH, bess AG, Berlin, Germany).
BA
Table 1 Cumulative doses of sedative and analgetic medications for 
rigid bronchoscopy in spontaneous ventilation
Case 1 Case 2 Case 3
Propofol (mg) 80 – 120
Remifentanil (µg) 540 410 490
Dexmedetomidine (µg) 105 150 160
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Figure 2 Rigid bronchoscopy of case 2. (A) lower tracheal view revealing a large, supracarinal TMF; (B) lower tracheal view, TMF covered 
with fibrin sealant; (C) lower tracheal view after stenting using an aerstent® Y Carina-Stent (Leufen, Medical GmbH, bess AG, Berlin, 
Germany).
Figure 3 Rigid bronchoscopy of case 3. (A) upper tracheal view with esophageal stent perforating the trachea; (B) lower tracheal view after 
stenting using an aerstent® Y Carina-Stent (Leufen, Medical GmbH, bess AG, Berlin, Germany); (C) upper tracheal view with persistent 
TEF above Y stent; (D) showing proximal stent extension using a partially covered, straight 16×40 mm UltraflexTM Stent (BostonScientific, 






However, in case of secondary tracheal compression with 
symptomatic central airway stenosis or penetration of 
the esophageal stent into the tracheobronchial system (as 
shown in case 1 and 3), or in case of TMF (case 2), tracheo-
(bronchial) stenting is the treatment option of choice. In 
this case, the anesthesiological and airway management 
becomes more complex. Basically, it is feasible to insert 
bronchial self-expandable stents using flexible bronchoscopy 
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in mild sedation only (7). However, TEF/TMF often 
require insertion of a Y or straight tracheal stent. Rigid 
bronchoscopy provides ideal prerequisites for safe gas 
exchange in combination with an adequate working channel 
for several procedures. To date, tracheal stenting using rigid 
bronchoscopy unconditionally requires general anesthesia 
and positive pressure or jet ventilation (1). The latter might 
need to advance the bronchoscope distally to the fistula, 
which impedes visualization and intervention. Therefore, 
the traditional technique requires apnea periods without 
any ventilation, which further stresses gas exchange and the 
very limited time to complete stent placement. Eventually, 
intraoperative fatal outcomes are not uncommon (8). A 
very recent study by Murgu et al. suggests that RB can 
be safely performed with total intravenous anesthesia 
and spontaneous ventilation (9). However, in their study 
dexmedetomidine was only used in two patients without 
evidence of the procedure details. Our three patients with 
severe TEF or TMF tolerated RB using dexmedetomidine 
without pain or stress after careful local anesthesia using 
lidocaine 10% spray. During potentially painful or stressful 
periods, its effect was supplemented with remifentanil and 
propofol. In addition, dexmedetomidine has been used 
in combination with small bolus’ of propofol (10–20 mg) 
to suppress coughing and for a safe insertion of the rigid 
bronchoscope according to Kim et al. (10). The sedation 
has been estimated by clinical assessment and the RASS 
(Richmond Agitation and Sedation Scale) with the aim 
of −1 to −2. Spontaneous breathing with sufficient (pre-)
oxygenation was maintained at all time in each patient using 
a face mask and through the bronchoscope, respectively. 
Meanwhile, the patients were monitored with non-invasive 
oxygen saturation, ECG, and arterial line to measure blood 
pressure and arterial O2 and CO2.
Eventually, a consented back-up plan in case of under- 
or oversedation must be considered before starting the 
procedure (i.e., return to traditional technique with general 
anesthesia and jet ventilation). Relevant prerequisites 
for this technique is ensuring that anatomy allows for 
intubation with a rigid bronchoscopy (oral opening, 
reclination) and a trustful patient-doctor relationship. 
Furthermore, the patient must be informed that he will not 
be able to speak during the procedure. Thus, a clear hand 
signaling must be arranged. 
In conclusion, the use of dexmedetomidine was of great 
benefit for the patients and confirmed the results of previous 
studies regarding spontaneous respiration and moderate 
sedation. Based on our experience, using dexmedetomidine 
spontaneous respiration can be safely maintained even 
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